Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -243,360 | -180,307 | -146,969 | -6,771 | -83 |
| Depreciation Amortization | 8,223 | 962 | 297 | N/A | N/A |
| Accounts payable and accrued liabilities | 6,984 | -1,399 | 2,085 | 57 | 103 |
| Other Working Capital | -244 | 12,228 | 15,022 | 994 | 103 |
| Other Operating Activity | 52,037 | 23,682 | 78,521 | -25 | -103 |
| Operating Cash Flow | $-176,360 | $-144,834 | $-51,044 | $-5,745 | $20 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 240,225 | -140,578 | -123,500 | N/A | N/A |
| PPE Investments | -1,503 | -2,966 | -3,490 | N/A | N/A |
| Other Investing Activity | -23,380 | -3,600 | -17,721 | 0 | 0 |
| Investing Cash Flow | $215,342 | $-147,144 | $-144,711 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 193,596 | 28,222 | N/A | 6,000 | 40 |
| Debt Repayment | N/A | N/A | -40 | 0 | N/A |
| Common Stock Issued | 118,944 | 293,356 | 0 | 0 | N/A |
| Other Financing Activity | 0 | 0 | 300,899 | 0 | 0 |
| Financing Cash Flow | $312,540 | $321,578 | $300,859 | $6,000 | $40 |
| Exchange Rate Effect | 9 | 70 | 0 | N/A | N/A |
| Beginning Cash Position | 135,089 | 105,419 | 315 | 60 | 60 |
| End Cash Position | 486,620 | 135,089 | 105,419 | 315 | 60 |
| Net Cash Flow | $351,531 | $29,670 | $105,104 | $255 | $60 |
| Free Cash Flow | |||||
| Operating Cash Flow | -176,360 | -144,834 | -51,044 | -5,745 | 20 |
| Capital Expenditure | -1,503 | -2,966 | -3,490 | 0 | N/A |
| Free Cash Flow | -177,863 | -147,800 | -54,534 | -5,745 | 20 |